Drug Trial Radar · NCT05648500
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
470
Actual
Start
Dec 13, 2022
Primary completion
Mar 31, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Viatris Innovation GmbHIndustry
- Sponsor type
- Industry
- First posted
- Dec 13, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to severe symptoms. The main questions it aims to answer are: * How well cenerimod works on top of the treatment already being administered. * How safe cenerimod is for adult patients with Systemic Lupus Erythematosus. Researchers will compare one dose of cenerimod and a placebo to see how well cenerimod works when it is added to the treatment already being administered. In this research study approximately 210 participants will receive cenerimod and approximately 210 participants will receive placebo for 12 months.
Conditions
- Lupus Erythematosus, Systemic
Interventions
CenerimodDrug
Cenerimod will be supplied as a film-coated tablets at the dose of 4 mg.
PlaceboDrug
Matching placebo will be supplied as identical film-coated tablets formulated with the same excipients but without the active ingredient, cenerimod.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response on Systemic Lupus Erythematosus Responder Index 4 (SRI-4) at Month 12 compared to baselineTime frame: At Month 12 compared to Day 1 (pre-dose baseline)
Locations
198 sites in 17 countries. Site status is shown where the registry gives one.
California Research Institute
Huntington Park, California
University of Colorado Denver
Aurora, Colorado
Clinical Research of West Florida, Inc.
Clearwater, Florida
Omega Research MetroWest, LLC
DeBary, Florida
Alloy Clinical Research, LLC
Kissimmee, Florida
SouthCoast Research Center, Inc.
Miami, Florida
Allied Biomedical Research Institute
Miami, Florida
Professional research Center INC
Miami, Florida
IRIS Research and Development, LLC
Plantation, Florida
Augusta University
Augusta, Georgia
Advance Quality Medical Research
Orland Park, Illinois
Accurate Clinical Research Inc. - Lake Charles
Lake Charles, Louisiana
Louisiana State University School of Medicine section of Rheumatology
New Orleans, Louisiana
Axon Clinical Research -Baltimore
Baltimore, Maryland
Bronx Care Health and Wellness Center
The Bronx, New York
DJL Clinical Research, PLLC
Charlotte, North Carolina
University of Oklahoma College of Medicine
Oklahoma City, Oklahoma
Accurate Clinical Research Inc.
Baytown, Texas
Rheumatology Care Center, PLLC
Bellaire, Texas
Houston MD Medspa and Wellness Clinic
Houston, Texas
Accurate Clinical Research Inc.
Houston, Texas
Sun Research Institute
San Antonio, Texas
Fundación Respirar
Buenos Aires, Argentina
Instituto Medico CER
Buenos Aires, Argentina
Aprillus Asistencia e Investigacion
Buenos Aires, Argentina
Arsema Clinica Adventista Belgrano
Buenos Aires, Argentina
IR Medical Center /Hospital de Día/ Instituto de Reumatología y Traumatología
Mendoza, Argentina
Instituto CAICI SRL
Rosario, Argentina
Centro de investigaciones medicas Tucuman
San Miguel de Tucumán, Argentina
Centro Integral de Reumatología
San Miguel de Tucumán, Argentina
ICT (Investigaciones Clínicas Tucumán)
San Miguel de Tucumán, Argentina
Santa Casa de Belo Horizonte
Belo Horizonte, Brazil
Centro Mineiro de Pesquisas
Juiz de Fora, Brazil
Instituto Méderi de Pesquisa e Saúde
Passo Fundo, Brazil
Centro Multidisciplinar de Pesquisa Clínica (Irmandade da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Brazil
LMK Servicos Medico S/S
Porto Alegre, Brazil
IMPAR SERVICOS HOSPITALARES S/A ; Hospital São Lucas
Rio de Janeiro, Brazil
SER - Serviços Especializados em Reumatologia da Bahia
Salvador, Brazil
Hospital de Clínicas de Porto Alegre
Santa Cecília, Brazil
Centro Multidiciplinar de Estudos Clínicos- CEMEC
São Bernardo do Campo, Brazil
Showing 40 of 198 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.